Vertaling van "al duration of breastfeeding " (Frans → Nederlands) :

[3] Thomas Harder1 et al. Duration of Breastfeeding and Risk of Overweight: A Meta-Analysis.
[3] Thomas Harder1 et al. Duration of Breastfeeding and Risk of Overweight: A Meta-Analysis.

[2] Kramer, M.S et al. Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding.
[2] Kramer, M.S et al. Infant growth and health outcomes associated with 3 compared with 6 mo of exclusive breastfeeding.

Design Population Intervention n Duration Outcomes Results
Design Population Intervention N/n Duration Outcomes Results

[1] Duration of Lactation and Risk Factors for Maternal Cardiovascular Disease – Schwarz et al.- Gynecol.
Duration of Lactation and Risk Factors for Maternal Cardiovascular Disease – Schwarz et al.- Obstet Gynecol.

Arch Intern Med 2006; 166:357-65. Vickers MR, MacLennan AH, Lawton B et al. Main morbidities recorded in the women’s international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women.
Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.

(1) La publication de référence suivante de W. Kissling est confirmée par une étude plus récente : W. Kissling, Duration of Neuroleptic Maintenance Treatment, in W. Kissling Guidelines for Neuroleptic Relapse Prevention, Springer Verlag Berlin Heidelberg, 1991, pp 95-107 (2) Même référence que pour 1.
(1) De volgende referentie publicatie van W. Kissling is bevestigd door recenter onderzoek: W. Kissling, Duration of Neuroleptic Maintenance Treatment, in W. Kissling Guidelines for Neuroleptic Relapse Prevention, Springer-Verlag Berlin Heidelberg, 1991, pp95-107 (2) Zelfde referentie als 1.

13. Guillemot D, Carbon C, Balkan B et al : Low dosage and long treatment duration of beta-lactam : risk factor for carriage of penicillin-resisiant Streptococcus pneumonies.
13. Guillemot D, Carbon C, Balkan B et al: Low dosage and long treatment duration of beta-lactam: risk factor for carriage of penicillin-resisiant Streptococcus pneumonies.

Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR Buproprion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.
Spontaneous cessation rate: 2.5% OR counselling only: 1.73 Incremental OR NRT gum (relative to counselling only): 1.63 Incremental OR NRT patch (relative to counselling only): 1.79 Incremental OR NRT spray (relative to counselling only): 2.35 Incremental OR NRT inhaler (relative to counselling only): 2.14 Incremental OR bupropion (relative to counselling only): 2.30 % of smokers still under treatment after the first month: 50% (range 40-60% in sensitivity analysis) % of smokers still under treatment after the second month: 20% (range 15-25% in sensitivity analysis) Lifetime relapse probability after one year of abstinence: 35% (range 10-50% in sensitivity analysis) Effect of smoking cessation on mortality derived from the results of the American Cancer Society Prevention Study II. The mortality rate for former smokers was projected by calculating a weighted average of the incremental differentials between mortality rates of neversmokers and smokers, weighted according to the duration of abstinence.

Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and Buproprion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.
Unit cost: €2.53 Costs of interventions in current practice based on Dutch empirical data Cost calculations of interventions in increased implementation program based on Dutch practice guidelines and (for the duration of NRT and bupropion) on international trials (Cochrane meta-analysis) Costs of smoking-related diseases were taken into account, estimates based on Dutch cost-ofillness study that allocated total direct health care costs to diseases.

Buproprion is assumed to be prescribed in two 4-week packs, given that the recommended duration of treatment is 7-9 weeks.
Bupropion is assumed to be prescribed in two 4-week packs, given that the recommended duration of treatment is 7-9 weeks.